Pa. Court Won't Rethink Axing Bar On Risperdal Punitives

Law360 (March 23, 2018, 6:47 PM EDT) -- The Pennsylvania Superior Court has denied a request for rehearing en banc of a ruling that shot down a global bar on punitive damage awards in the thousands of Risperdal-related personal injury cases pending against Johnson & Johnson unit Janssen Pharmaceuticals Inc. as part of a mass tort program in Philadelphia County.

The appeals court's order — handed down March 16 and posted Friday as part of its weekly rehearing report — follows a January finding that an order barring punitive damages in each of the over 6,400 Risperdal-related cases pending in Philadelphia had improperly prevented a Wisconsin resident from arguing that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!